AUPO888497A0 - Creation of Inventions and Patents with Artificial Intelligence

AUPO888497A0 – Use of sulfated oligosaccharides as inhibitors of cardiovascular disease
– Google Patents

AUPO888497A0 – Use of sulfated oligosaccharides as inhibitors of cardiovascular disease
– Google Patents
Use of sulfated oligosaccharides as inhibitors of cardiovascular disease

Info

Publication number
AUPO888497A0

AUPO888497A0
AUPO8884A
AUPO888497A
AUPO888497A0
AU PO888497 A0
AUPO888497 A0
AU PO888497A0
AU PO8884 A
AUPO8884 A
AU PO8884A
AU PO888497 A
AUPO888497 A
AU PO888497A
AU PO888497 A0
AUPO888497 A0
AU PO888497A0
Authority
AU
Australia
Prior art keywords
inhibitors
cardiovascular disease
sulfated oligosaccharides
sulfated
oligosaccharides
Prior art date
1997-09-01
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Application number
AUPO8884A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Australian National University

Original Assignee
Australian National University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1997-09-01
Filing date
1997-09-01
Publication date
1997-09-25

1997-09-01
Application filed by Australian National University
filed
Critical
Australian National University

1997-09-01
Priority to AUPO8884A
priority
Critical
patent/AUPO888497A0/en

1997-09-25
Publication of AUPO888497A0
publication
Critical
patent/AUPO888497A0/en

1998-08-31
Priority to ZA987904A
priority
patent/ZA987904B/en

1998-09-01
Priority to JP2000508375A
priority
patent/JP2001514229A/en

1998-09-01
Priority to AU88457/98A
priority
patent/AU726883B2/en

1998-09-01
Priority to CN98809672A
priority
patent/CN1272060A/en

1998-09-01
Priority to US09/486,617
priority
patent/US6638916B1/en

1998-09-01
Priority to BR9811422-0A
priority
patent/BR9811422A/en

1998-09-01
Priority to CA002302154A
priority
patent/CA2302154A1/en

1998-09-01
Priority to EP98939988A
priority
patent/EP1024813A4/en

1998-09-01
Priority to TW087114460A
priority
patent/TW438594B/en

1998-09-01
Priority to IL13476198A
priority
patent/IL134761A0/en

1998-09-01
Priority to PCT/AU1998/000707
priority
patent/WO1999011273A1/en

Status
Abandoned
legal-status
Critical
Current

Links

Espacenet

Global Dossier

Discuss

Classifications

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K31/00—Medicinal preparations containing organic active ingredients

A61K31/70—Carbohydrates; Sugars; Derivatives thereof

A61K31/7024—Esters of saccharides

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K31/00—Medicinal preparations containing organic active ingredients

A61K31/70—Carbohydrates; Sugars; Derivatives thereof

A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

A61P9/00—Drugs for disorders of the cardiovascular system

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

A61P9/00—Drugs for disorders of the cardiovascular system

A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

AUPO8884A
1997-09-01
1997-09-01
Use of sulfated oligosaccharides as inhibitors of cardiovascular disease

Abandoned

AUPO888497A0
(en)

Priority Applications (12)

Application Number
Priority Date
Filing Date
Title

AUPO8884A

AUPO888497A0
(en)

1997-09-01
1997-09-01
Use of sulfated oligosaccharides as inhibitors of cardiovascular disease

ZA987904A

ZA987904B
(en)

1997-09-01
1998-08-31
Use of sulfated oligosaccharides as inhibitors of cardiovascular disease

PCT/AU1998/000707

WO1999011273A1
(en)

1997-09-01
1998-09-01
Use of sulfated oligosaccharides as inhibitors of cardiovascular disease

CN98809672A

CN1272060A
(en)

1997-09-01
1998-09-01
Use of sulfated oligosaccharides as inhibitors of cardiovascular disease

AU88457/98A

AU726883B2
(en)

1997-09-01
1998-09-01
Use of sulfated oligosaccharides as inhibitors of cardiovascular disease

JP2000508375A

JP2001514229A
(en)

1997-09-01
1998-09-01

Use of sulfated oligosaccharides as inhibitors of cardiovascular disease

US09/486,617

US6638916B1
(en)

1997-09-01
1998-09-01
Use of sulfated oligosaccharides as inhibitors of cardiovascular disease

BR9811422-0A

BR9811422A
(en)

1997-09-01
1998-09-01

Process for inhibiting vascular smooth muscle cell hyperplasia in a human patient or other warm-blooded animal patient requiring such treatment, use of at least one sulfated oligosaccharide, and pharmaceutical or veterinary composition for inhibiting muscle cell hyperplasia vascular smooth

CA002302154A

CA2302154A1
(en)

1997-09-01
1998-09-01
Use of sulfated oligosaccharides as inhibitors of cardiovascular disease

EP98939988A

EP1024813A4
(en)

1997-09-01
1998-09-01
Use of sulfated oligosaccharides as inhibitors of cardiovascular disease

TW087114460A

TW438594B
(en)

1997-09-01
1998-09-01
Pharmaceutical composition for the inhibition of vascular smooth muscle cell hyperplasia

IL13476198A

IL134761A0
(en)

1997-09-01
1998-09-01
Use of sulfated oligosaccharides as inhibitors of cardiovascular disease

Applications Claiming Priority (1)

Application Number
Priority Date
Filing Date
Title

AUPO8884A

AUPO888497A0
(en)

1997-09-01
1997-09-01
Use of sulfated oligosaccharides as inhibitors of cardiovascular disease

Publications (1)

Publication Number
Publication Date

AUPO888497A0
true

AUPO888497A0
(en)

1997-09-25

Family
ID=3803170
Family Applications (1)

Application Number
Title
Priority Date
Filing Date

AUPO8884A
Abandoned

AUPO888497A0
(en)

1997-09-01
1997-09-01
Use of sulfated oligosaccharides as inhibitors of cardiovascular disease

Country Status (11)

Country
Link

US
(1)

US6638916B1
(en)

EP
(1)

EP1024813A4
(en)

JP
(1)

JP2001514229A
(en)

CN
(1)

CN1272060A
(en)

AU
(1)

AUPO888497A0
(en)

BR
(1)

BR9811422A
(en)

CA
(1)

CA2302154A1
(en)

IL
(1)

IL134761A0
(en)

TW
(1)

TW438594B
(en)

WO
(1)

WO1999011273A1
(en)

ZA
(1)

ZA987904B
(en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

SE0101854L
(en)

2001-05-28
2002-11-29
Bioneris Ab

Use of a compound with a negatively charged region of groups for the treatment of restenosis.

EP1709443A2
(en)

2003-12-18
2006-10-11
Procognia, Ltd.
Method for analyzing a glycomolecule

BRPI0813420B1
(en)

2007-06-28
2018-05-15
Basf Beauty Care Solutions France Sas

Use of a preparation, composition, and cosmetic method of care for weight loss

EP3166981A4
(en)

2014-07-09
2018-03-07
Cadena Bio, Inc.
Oligosaccharide compositions and methods for producing thereof

MX2017009730A
(en)

2015-01-26
2018-06-11
Cadena Bio Inc
Oligosaccharide compositions for use animal feed and methods of producing thereof.

CN116270718A
(en)

2015-04-23
2023-06-23
Dsm营养产品有限责任公司
Glycan therapeutic and methods of treatment

WO2017083520A1
(en)

2015-11-13
2017-05-18
Cadena Bio, Inc.
Animal therapeutic and feed compositions and methods of use

Family Cites Families (21)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

JPS55105700A
(en)

1979-02-09
1980-08-13
Yamasa Shoyu Co Ltd
S-adenosyl-l-methionine-containing composition and its preparation

FR2535324A1
(en)

1982-10-27
1984-05-04
Choay Sa

PERFECTED STATION FOR THE PURIFICATION OF WASTEWATER

AU563351C
(en)

1982-01-15
2003-06-19
Glaxo Group Limited
Synthesis of oligosaccharides

US5308838A
(en)

1982-05-07
1994-05-03
Carrington Laboratories, Inc.
Uses of aloe products

IT1195497B
(en)

1983-03-08
1988-10-19
Opocrin Spa

PROCEDURE FOR THE PREPARATION OF OLIGOSACCHARIDIC FRACTIONS EQUIPPED WITH PHARMACOLOGICAL PROPERTIES FOR CHEMICAL DEGRADATION OF HEPARIN

FR2584606A1
(en)

1985-07-12
1987-01-16
Dropic

USE OF POLY- AND OLIGOSACCHARIDES FOR THE PRODUCTION OF ACTIVE MEDICAMENTS IN THE PATHOLOGIES OF CONNECTIVE TISSUE

IT1230582B
(en)

1988-10-21
1991-10-28
Opocrin S P A Lab Farmabiologi

DERMATAN SULPHATE AND HEPARIN OILGOSACCHARID WITH ANTI-THEROSCLEROTIC ACTIVITIES

US5298616A
(en)

1990-10-03
1994-03-29
Hoffmann-La Roche Inc.
Sulfated O-polysaccharide-trehaloses

IT1242604B
(en)

1990-11-13
1994-05-16
Alfa Wassermann Spa

GLYCOSAMINOGLICAN SALTS WITH AMINO ACID ESTERS, THEIR PREPARATION AND PHARMACEUTICAL FORMULATIONS THAT CONTAIN THEM.

CA2061370A1
(en)

1991-03-13
1992-09-14
Markus Hosang
Pharmaceutical preparations

AU1902592A
(en)

1991-04-17
1992-11-17
Glycomed Incorporated
Sulfated polysaccharides as inhibitors of smooth muscle cell proliferation

IT1251182B
(en)

1991-08-28
1995-05-04
Opocrin Spa

DERMATAN SULPHATE OLIGOSACCHARIDES, PROCESS FOR THEIR PRODUCTION AND RELATED PHARMACEUTICAL COMPOSITIONS.

AU678760B2
(en)

1991-11-11
1997-06-12
Trustees Of The University Of Pennsylvania, The
Methods of inhibiting restenosis

GB9206291D0
(en)

1992-03-23
1992-05-06
Cancer Res Campaign Tech
Oligosaccharides having growth factor binding affinity

FR2704226B1
(en)

1993-04-22
1995-07-21
Sanofi Elf

3-DESOXY OLIGOSACCHARIDES, THEIR PREPARATION PROCESSES AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.

US5739115A
(en)

1993-10-07
1998-04-14
Glycomed Incorporated
Sulfated maltooligosaccharides with heparin-like properties

CA2171465A1
(en)

1993-10-07
1995-04-13
Peter Fugedi
Highly sulfated maltooligosaccharides with heparin-like properties

AU2560995A
(en)

1994-06-06
1996-01-04
Per Bjorn Ostergaard
A pharmaceutical composition comprising oligosaccharides binding to lipoprotein lipase

US5464827A
(en)

1994-06-20
1995-11-07
American Home Products Corporation
Esterified polyanionic cyclodextrins as smooth muscle cell proliferation inhibitors

AUPN261895A0
(en)

1995-04-28
1995-05-18
Australian National University, The
Preparation and use of sulfated oligosaccharides

CA2212458C
(en)

1995-12-20
2001-08-28
Taiho Pharmaceutical Co., Ltd.
Vascular intimal hyperplasia-inhibitory composition

1997

1997-09-01
AU
AUPO8884A
patent/AUPO888497A0/en
not_active
Abandoned

1998

1998-08-31
ZA
ZA987904A
patent/ZA987904B/en
unknown

1998-09-01
BR
BR9811422-0A
patent/BR9811422A/en
not_active
IP Right Cessation

1998-09-01
JP
JP2000508375A
patent/JP2001514229A/en
not_active
Withdrawn

1998-09-01
EP
EP98939988A
patent/EP1024813A4/en
not_active
Withdrawn

1998-09-01
CA
CA002302154A
patent/CA2302154A1/en
not_active
Abandoned

1998-09-01
TW
TW087114460A
patent/TW438594B/en
not_active
IP Right Cessation

1998-09-01
US
US09/486,617
patent/US6638916B1/en
not_active
Expired – Fee Related

1998-09-01
WO
PCT/AU1998/000707
patent/WO1999011273A1/en
not_active
Application Discontinuation

1998-09-01
IL
IL13476198A
patent/IL134761A0/en
unknown

1998-09-01
CN
CN98809672A
patent/CN1272060A/en
active
Pending

Also Published As

Publication number
Publication date

EP1024813A4
(en)

2002-08-28

JP2001514229A
(en)

2001-09-11

US6638916B1
(en)

2003-10-28

CN1272060A
(en)

2000-11-01

ZA987904B
(en)

1999-03-01

BR9811422A
(en)

2000-08-22

IL134761A0
(en)

2001-04-30

TW438594B
(en)

2001-06-07

CA2302154A1
(en)

1999-03-11

EP1024813A1
(en)

2000-08-09

WO1999011273A1
(en)

1999-03-11

Contact information